BACKGROUND AND PURPOSE: Endovascular treatment of intracranial aneurysms is
associated with the risk of thromboembolic ischemic complications. Many of these events …

Background The decision for treatment for unruptured intracranial aneurysms (UIAs) is often
difficult. Innovation in endovascular devices have improved the benefit-to-risk profile for …

BACKGROUND The use of antiplatelet medications to prevent thrombosis in the treatment of
cerebral aneurysms with stents has become widely emphasized. OBJECTIVE To compare …

BACKGROUND Antiplatelet premedication is widely accepted for interventional treatment of
cerebral aneurysms to prevent thromboembolism. However, antiplatelet resistance …

BACKGROUND AND PURPOSE: Prophylactic antiplatelet medication is beneficial in
decreasing thromboembolic complications during endovascular treatment of unruptured …

Background This meta-analysis aimed to evaluate the association between antiplatelet
resistance and the risk of procedure-related complications in neurovascular interventions …

Background In endovascular treatment for cerebral aneurysms, the appearance of
asymptomatic thromboembolic lesions detected by postprocedural diffusion-weighted …

Endovascular techniques have expanded to include balloon and stent-assistance, flow
diversion and individualized endovascular occlusion devices, to widen the treatment …

BACKGROUND AND PURPOSE: DWI-detected ischemic lesions are potential complications
of endovascular procedures that are performed to treat intracranial aneurysms. We …

OBJECTIVE The authors sought to demonstrate that hemorrhagic transformation of ischemic
lesions is the main cause of delayed intracerebral hemorrhage (ICH) after Pipeline …